These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 11989672)
1. Role of liquid membrane phenomenon in biological actions of ACE inhibitors, captopril and lisinopril. Nagappa AN; Patil RT; Pandi V; Ziauddin K Indian J Biochem Biophys; 2001 Dec; 38(6):412-6. PubMed ID: 11989672 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril. Udupa EG; Rao NM Indian J Biochem Biophys; 1997 Dec; 34(6):524-8. PubMed ID: 9594434 [TBL] [Abstract][Full Text] [Related]
3. Inhibitory action of the peptide AcSDKP on the proliferative state of hematopoietic stem cells in the presence of captopril but not lisinopril. Chisi JE; Wdzieczak-Bakala J; Riches AC Stem Cells; 1997; 15(6):455-60. PubMed ID: 9402658 [TBL] [Abstract][Full Text] [Related]
4. A calorimetric study of the binding of lisinopril, enalaprilat and captopril to angiotensin-converting enzyme. Andújar-Sánchez M; Cámara-Artigas A; Jara-Pérez V Biophys Chem; 2004 Oct; 111(2):183-9. PubMed ID: 15381315 [TBL] [Abstract][Full Text] [Related]
5. Characterization of angiotensin-converting enzyme in canine testis. Sabeur K; Vo AT; Ball BA Reproduction; 2001 Jul; 122(1):139-46. PubMed ID: 11425338 [TBL] [Abstract][Full Text] [Related]
6. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat. Sacco G; Mario B; Lopez G; Evangelista S; Manzini S; Maggi CA Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651 [TBL] [Abstract][Full Text] [Related]
7. Free radical scavenging properties of alacepril metabolites and lisinopril. Noda Y; Mori A; Packer L Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):125-36. PubMed ID: 9226747 [TBL] [Abstract][Full Text] [Related]
8. Role of liquid membrane phenomenon in the biological actions of prostaglandins: studies on prostaglandin E1 and prostaglandin F2 alpha. Nagappa AN; Raju DB; Srivastava RC Indian J Biochem Biophys; 1989 Jun; 26(3):172-7. PubMed ID: 2620912 [TBL] [Abstract][Full Text] [Related]
9. Evidence for stimulation of neutrophil degranulation by selected angiotensin converting enzyme inhibitors in vitro. Miselis J; Siminiak T; Wysocki H J Hum Hypertens; 1994 Aug; 8(8):565-9. PubMed ID: 7990082 [TBL] [Abstract][Full Text] [Related]
11. The effect of angiotensin-converting enzyme inhibitors on experimental colitis in rats. Jahovic N; Ercan F; Gedik N; Yüksel M; Sener G; Alican I Regul Pept; 2005 Aug; 130(1-2):67-74. PubMed ID: 15908024 [TBL] [Abstract][Full Text] [Related]
12. Role of liquid membrane phenomenon in the biological actions of thioridazine. Nagappa AN; Kole PL; Srinivas D; Vivek D; Ullas DP; Srivastava RC Colloids Surf B Biointerfaces; 2005 Jun; 43(1):21-7. PubMed ID: 15893459 [TBL] [Abstract][Full Text] [Related]
13. Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors. Van Antwerpen P; Legssyer I; Zouaoui Boudjeltia K; Babar S; Moreau P; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J Eur J Pharmacol; 2006 May; 537(1-3):31-6. PubMed ID: 16631159 [TBL] [Abstract][Full Text] [Related]
14. CX3CR1 receptor is up-regulated in monocytes of coronary artery diseased patients: impact of pre-inflammatory stimuli and renin-angiotensin system modulators. Apostolakis S; Krambovitis E; Vlata Z; Kochiadakis GE; Baritaki S; Spandidos DA Thromb Res; 2007; 121(3):387-95. PubMed ID: 17521710 [TBL] [Abstract][Full Text] [Related]
15. Captopril and lisinopril suppress production of interleukin-12 by human peripheral blood mononuclear cells. Constantinescu CS; Goodman DB; Ventura ES Immunol Lett; 1998 May; 62(1):25-31. PubMed ID: 9672144 [TBL] [Abstract][Full Text] [Related]
16. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat. Sulpizio AC; Pullen MA; Edwards RM; Brooks DP J Pharmacol Exp Ther; 2004 Jun; 309(3):1141-7. PubMed ID: 14769834 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction. Ahmad M; White R; Tan J; Huang BS; Leenen FH J Cardiovasc Pharmacol; 2008 Jun; 51(6):565-72. PubMed ID: 18496146 [TBL] [Abstract][Full Text] [Related]
18. Effect of protease inhibitors on angiotensin-converting enzyme activity in human T-lymphocytes. Petrov V; Fagard R; Lijnen P Am J Hypertens; 2000 May; 13(5 Pt 1):535-9. PubMed ID: 10826406 [TBL] [Abstract][Full Text] [Related]
19. Effect of angiotensin-converting enzyme inhibitors on liver regeneration in rats. Ramalho FS; Ramalho LN; Castro-e-Silva Júnior O; Zucoloto S; Corrêa FM Hepatogastroenterology; 2002; 49(47):1347-51. PubMed ID: 12239940 [TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme-like activity in crab gills and its putative role in degradation of crustacean hyperglycemic hormone. Chung JS; Webster SG Arch Insect Biochem Physiol; 2008 Jul; 68(3):171-80. PubMed ID: 18481304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]